The oral solution Bilargo contains Bilastine and is made by Ziska Pharmaceuticals Ltd. Bilargo is used for the symptomatic treatment of allergic rhino-conjunctivitis, which may be seasonal or perennial, and of urticaria.
There are 82 brands of Bilastine listed in Bangladesh. 46 of them have a lower unit price than Bilargo. The lowest listed price is Blastine 20 mg Tablet at ৳ 10 per unit.
What is Bilargo 12.5 mg/5 ml Oral Solution?
Bilargo 12.5 mg/5 ml is a oral solution product of Ziska Pharmaceuticals Ltd. that contains Bilastine. Like any medicine, it should be used only as advised by a doctor, who will decide whether it is appropriate for you and how it should be taken. It is long-acting and has no affinity for muscarinic receptors. The doctor decides whether it suits you and how it should be taken.
Uses of Bilargo
Bilargo is used for the symptomatic treatment of allergic rhino-conjunctivitis, which may be seasonal or perennial, and of urticaria. A doctor decides whether this medicine suits a particular person and what the treatment plan should be. It is a non-sedating antihistamine. Ask your doctor whether it is right for your condition.
How to use Bilargo
Take Bilargo exactly as your doctor prescribes. Do not change the dose or stop early without asking your doctor. Complete the course exactly as prescribed.
Side effects of Bilargo
Call the doctor if you notice any side effect that worries you, if it does not go away, or if you feel unwell. The side effects most commonly reported with Bilastine in clinical trials are headache, dizziness, somnolence and fatigue, and these occurred with a frequency similar to placebo. Your doctor or pharmacist can advise on what to do next. Contact your doctor promptly if a side effect worries you, does not settle, or seems to be getting worse. Tell your doctor if you notice any of these or any other unusual effect.
Safety and precautions
Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity, parturition or postnatal development. The excretion of Bilastine in milk has not been studied in humans. Bilastine is contraindicated in patients with hypersensitivity to the active substance or to any of the excipients of the tablet. Ask your doctor first if any of these apply to you.
Frequently asked questions
Why is Bilargo prescribed?
Bilargo is used for the symptomatic treatment of allergic rhino-conjunctivitis, which may be seasonal or perennial, and of urticaria. A doctor decides whether this medicine suits a particular person and what the treatment plan should be.
How is Bilargo used?
Take Bilargo exactly as your doctor prescribes. Do not change the dose or stop early without asking your doctor.
What are the side effects of Bilargo?
Call the doctor if you notice any side effect that worries you, if it does not go away, or if you feel unwell. The side effects most commonly reported with Bilastine in clinical trials are headache, dizziness, somnolence and fatigue, and these occurred with a frequency similar to placebo.
Bilastine is indicated for symptomatic treatment of allergic rhino-conjunctivitis (seasonal and perennial) and urticaria.
Pharmacology
Bilastine is a non-sedating, long-acting histamine antagonist with selective peripheral H 1 receptor antagonist affinity and no affinity for muscarinic receptors. Bilastine inhibits histamine-induced wheal and flare skin reactions for 24 hours following single doses.
Dosage & Administration
Adults & adolescents (12 years of age and over): 20 mg tablet once daily for symptomatic relief of allergic rhinitis, urticaria and allergic rhinoconjunctivitis. The maximum recommended daily dose is 20 mg Bilastine (1 tablet) and should not be exceeded. If a dose is missed, the next scheduled dose should be taken. An extra dose should not be taken. 20 mg Bilastine tablet (1 tablet) once daily should be swallowed with water on an empty stomach to achieve optimal exposure to Bilastine.
Children between 6 to 11 years: 10 mg mouth dissolving tablet for the symptomatic relief of allergic rhinitis, allergic rhinoconjunctivitis and urticaria. The Mouth dissolving tablet is for oral use only. It should be placed in the mouth. It will disperse rapidly in saliva and can be easily swallowed. Alternatively, the mouth dissolving tablet can be dispersed in a tea spoon of water before being swallowed by the children. The maximum recommended daily dose for children in between 6 to 11 years is 10 mg Bilastine mouth dissolving tablet (1 tablet) and should not be exceeded. If a dose is missed, the next scheduled dose should be taken. An extra dose should not be taken.
Children between 2 to 11 years: 4 ml once daily.
Interaction
Concomitant intake of Bilastine and Ketoconazole or Erythromycin or Diltiazem increased C max of Bilastine. The psychomotor performance after concomitant intake of alcohol and Bilastine was similar to that observed after intake of alcohol and placebo. Concomitant intake of Bilastine and Lorazepam 3 mg for 8 days did not potentiate the depressant CNS effects of Lorazepam.
Contraindications
Bilastine is contraindicated in patients with hypersensitivity to the active substance or to any of the excipients of the tablet.
Side Effects
The most commonly reported side effects in clinical trial are headache, dizziness, somnolence and fatigue. These adverse events occurred with a comparable frequency in patients receiving placebo.
Pregnancy & Lactation
There are no or limited amount of data from the use of Bilastine in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity, parturition or postnatal development. As a precautionary measure, it is preferable to avoid the use of Bilastine during pregnancy. The excretion of Bilastine in milk has not been studied in humans. A decision must be made taking into account the benefit of breast-feeding for the child and the benefit of Bilastine therapy for the mother.
Precautions & Warnings
Co-administration of Bilastine and P-glycoprotein inhibitors (e.g. Ketoconazole, Erythromycin, Cyclosporine, Ritonavir or Diltiazem) should be avoided in patients with moderate or severe renal impairment.
Overdose Effects
In clinical trials, after administration of Bilastine at doses 10 to 11 times the therapeutic dose (220 mg as single dose; or 200 mg/day for 7 days) frequency of treatment-emergent adverse events was two times higher than with placebo. The adverse reactions most frequently reported were dizziness, headache and nausea. No serious adverse events and no significant prolongation in the QTc interval were reported.
Storage Conditions
Keep below 30°C temperature, protected from light and moisture. Keep out of reach of children.
Alternative brands of Bilastine
Other brands with the same generic name, cheapest first.